To the editor: adverse effects of ceftazidime treatment

Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis.

Journal of personalized medicine·2026

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study.

JHLT open·2025

Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024

The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort.

Clinics (Sao Paulo, Brazil)·2023

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis.

EClinicalMedicine·2023

Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease.

Pediatric pulmonology·2023

Clinical Outcomes of Chronic Airway Infection in Primary Ciliary Dyskinesia.

Pediatric pulmonology·2026

Neonatal Course and Long-Term Outcome in Children With Congenital Chylothorax.

Pediatric pulmonology·2026

CFTR Modulator Therapy and Aerobic Fitness Changes in Aerobic Fitness Following Initiation of CFTR Modulator Therapy: A Systematic Review and Meta-Analysis.

Pediatric pulmonology·2026

Hyperpolarized 129Xe MRI in Pediatric Hematopoietic Stem Cell Transplant Recipients With and Without Bronchiolitis Obliterans Syndrome.

Pediatric pulmonology·2026

Data Collection and Harmonization in Preterm Respiratory Research: Recommendations and Insights From PELICAN.

Pediatric pulmonology·2026

Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula.

Pediatric pulmonology·2026

Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.

Antimicrobial agents and chemotherapy·2026

Impact of PBP3 insertions and β-lactamase-encoding genes on the susceptibility of Escherichia coli isolates belonging to high-risk clones against aztreonam-avibactam and comparator agents.

Antimicrobial agents and chemotherapy·2026

Correlation between ACE2 and monocrotaline-induced pulmonary arterial hypertension in rats.

Experimental lung research·2026

Loss of Vacuole Membrane Protein 1 Protects Against Acetaminophen-induced Liver Injury by Modulating Inflammation and Hepatocyte Proliferation.

Toxicological sciences : an official journal of the Society of Toxicology·2026

Mutations in the macrodomain 1 of nsp3 attenuate PEDV virulence in vivo without impairing in vitro replication.

Journal of virology·2026

Atypical infections caused by pathogenic Neisseria species N. meningitidis and N. gonorrhoeae.

Clinical microbiology reviews·2026

Related Experiment Videos

To the editor: adverse effects of ceftazidime treatment

Related Concept Videos

Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis.

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study.

Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study.

The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort.

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis.

Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease.

Clinical Outcomes of Chronic Airway Infection in Primary Ciliary Dyskinesia.

Neonatal Course and Long-Term Outcome in Children With Congenital Chylothorax.

CFTR Modulator Therapy and Aerobic Fitness Changes in Aerobic Fitness Following Initiation of CFTR Modulator Therapy: A Systematic Review and Meta-Analysis.

Hyperpolarized 129Xe MRI in Pediatric Hematopoietic Stem Cell Transplant Recipients With and Without Bronchiolitis Obliterans Syndrome.

Data Collection and Harmonization in Preterm Respiratory Research: Recommendations and Insights From PELICAN.

Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula.

Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.

Impact of PBP3 insertions and β-lactamase-encoding genes on the susceptibility of Escherichia coli isolates belonging to high-risk clones against aztreonam-avibactam and comparator agents.

Correlation between ACE2 and monocrotaline-induced pulmonary arterial hypertension in rats.

Loss of Vacuole Membrane Protein 1 Protects Against Acetaminophen-induced Liver Injury by Modulating Inflammation and Hepatocyte Proliferation.

Mutations in the macrodomain 1 of nsp3 attenuate PEDV virulence in vivo without impairing in vitro replication.

Atypical infections caused by pathogenic Neisseria species N. meningitidis and N. gonorrhoeae.

Related Experiment Videos

To the editor: adverse effects of ceftazidime treatment

Related Concept Videos

Related Articles